Catalys Pacific
Ashwin is a Vice President with Catalys Pacific, a physician-scientist and biotechnology entrepreneur. He is the founder and CEO of Jupiter Therapeutics, Inc. a preclinical biotech company focused on cell vesicles. Before launching Jupiter he worked as a radiation oncologist and for Genentech’s Early Clinical Development Oncology team.
Ashwin completed his MD at the University of Michigan Medical School with AOA honors and Dean’s distinction in research. After training in radiation oncology at Johns Hopkins Hospital–where he received the Rangos award for creativity in cancer discovery, he completed an MS in bioengineering at Caltech and a postdoc at Stanford University as an NIH/NCI Cancer Translational Nanotechnology fellow.
This person is not in any offices
Catalys Pacific
Catalys Pacific begins operations as one of Japanʼs largest life sciences-focused investment firms. The firmʼs mission is to provide solutions to unmet medical needs for patients worldwide by creating and investing in companies that drive innovation in life sciences. Catalys Pacific maintains a strictly independent governance structure that ensures autonomous assessment and decision-making of its investments.